Filing Details
- Accession Number:
- 0001181431-13-054639
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-21 17:05:04
- Reporting Period:
- 2013-10-16
- Filing Date:
- 2013-10-21
- Accepted Time:
- 2013-10-21 17:05:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 722104 | Savient Pharmaceuticals Inc | SVNT | Medicinal Chemicals & Botanical Products (2833) | 133033811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466001 | Ginger Constantine | Savient Pharmaceuticals, Inc. 400 Crossing Blvd, 3Rd Floor Bridgewater NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-10-16 | 8,805 | $0.07 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
